U.S. National Institutes of Health  |  www.cancer.gov
NCI Cancer Bulletin: A Trusted Source for Cancer Research News
NCI Cancer Bulletin: A Trusted Source for Cancer Research News
August 19, 2008 • Volume 5 / Number 17 E-Mail This Document  |  Download PDF  |  Bulletin Archive/Search  |  Subscribe


Bulletin Home

Director's Update
The Dawn of Personalized Oncology

Mobilizing National Drug Discovery

Personalized Drug Development

A New Paradigm for Drug Discovery

Treatment Arsenal Expands with Small Chemicals

CMap Extends Drug Use

Clinical Trials and Personalized Drugs

The PPWG

Collaborating with Industry to Drive Drug Development

Helping Technology Collaborations Flourish

Other Resources

Cancer Research Highlights
Breast Cancer Relapse Risk Low after Chemotherapy or Tamoxifen

Novel Monoclonal Antibody Effective in Some Relapsed NHL Patients

Cord-Blood Transplant into Bone Restores Blood Counts

Esophageal Adenocarcinoma Rates Rise in Men and Women

Suicide Risk Higher in Cancer Patients than the General Population

Vitamin C Injections Slow Tumor Growth in Mice

Bulletin Archive

About the Bulletin
Page Options
Print This Page  Print This Page
Print This Document  Print This Document
View Entire Document  View Entire Document
E-Mail This Document  E-Mail This Document
PDF Version  View/Print PDF
Personalized Drug Development

A diagram that illustrates the process of learning about cancer biology, identifying targets for treatment or prevention, chemical analysis to determine drugs that can hit those targets, and how imaging and peripheral blood and tissue analysis will allow for less-invasive follow up that is easier on patients.

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov